Research

Atypical RNA interference effectors – mirtrons –  may be applicable for replacement genes treating dominant retinitis pigmentosa (RP).

A clinical research team, based at the Nuffield Laboratory of Ophthalmology, John Radcliffe Hospital, Oxford, has published a report on the treatment of RNAi effectors… Read More »Atypical RNA interference effectors – mirtrons –  may be applicable for replacement genes treating dominant retinitis pigmentosa (RP).